FZMD vs ABT: Which Stock is Better?
Side-by-side comparison of Fuse Medical, Inc. and Abbott Laboratories in 2026
FZMD
Fuse Medical, Inc.
$0.04
ABT
Abbott Laboratories
$96.81
Key Metrics Comparison
| Metric | FZMD | ABT | Winner |
|---|---|---|---|
| Market Cap | $2.96M | $168.23B | ABT |
| P/E Ratio | 1.33 | 26.74 | FZMD |
| EPS (TTM) | $0.03 | $3.62 | ABT |
| Revenue Growth | 0.1% | 0.1% | ABT |
| Gross Margin | 67.2% | 56.5% | FZMD |
Analyze FZMD
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FZMD or ABT a better investment?
Comparing FZMD and ABT: Fuse Medical, Inc. has a market cap of $2.96M while Abbott Laboratories has $168.23B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FZMD and ABT?
FZMD (Fuse Medical, Inc.) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FZMD or ABT?
Based on P/E ratios, FZMD trades at a lower multiple (1.3x vs 26.7x).
Which is growing faster: FZMD or ABT?
ABT has higher revenue growth at 0.1% vs 0.1% for FZMD.
Which company is more profitable: FZMD or ABT?
Fuse Medical, Inc. (FZMD) has higher gross margins at 67.2% compared to 56.5% for ABT.
Which is the larger company: FZMD or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $168.23B compared to $2.96M for FZMD.
Should I buy FZMD or ABT in 2026?
Both FZMD and ABT have investment merit. FZMD trades at $0.04 while ABT trades at $96.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FZMD and ABT stock?
Key differences: Market Cap ($2.96M vs $168.23B), P/E Ratio (1.3x vs 26.7x), Revenue Growth (0.1% vs 0.1%), Gross Margin (67.2% vs 56.5%).